ArticleScientific reports2026
Hyaluronic Acid-Phospholipid Hybrid Nanocarriers (Hyalutocosomes) for Enhanced Dermal Delivery of Vitamin E and Photoprotection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultraviolet (UV) radiation drives oxidative stress, inflammation, and collagen degradation, making efficient dermal delivery of antioxidants a key challenge in skin nanobiotechnology. In this study, we developed vitamin E (α-tocopherol)–loaded hyalutocosomes, a hyaluronic acid–decorated deformable phospholipid vesicle system related to previously reported hyalurosomes, and incorporated them into a collagen/vitamin C nanogel to enhance cutaneous penetration and retention. The nanocarriers showed a uniform size of about 160 nm with low polydispersity and very high encapsulation efficiency (~ 99%), and electron microscopy confirmed a distinct HA-coated core–shell morphology. In a UVB-irradiated rat model, the hyalutocosomes-loaded nanogel restored antioxidant enzymes (SOD, CAT) from approximately one-fifth toward near-normal levels, reduced UVB-induced elevations of IL-6, TNF-α, and MMP-9, and improved histological features, including epidermal hyperplasia and collagen disorganization, more effectively than free vitamin E or blank gel. Overall, these results indicate that hyalutocosomes, as an HA-vesicle–based nanocarrier integrated within a collagen biomaterial matrix, can enhance the topical bioavailability of lipophilic antioxidants and provide a promising platform for next-generation anti-photoaging interventions.
Indexed as
Identifiers
41922450What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.